{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:42:46Z","timestamp":1782236566285,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T00:00:00Z","timestamp":1311638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00277-011-1293-1","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T12:29:57Z","timestamp":1311596997000},"page":"243-248","source":"Crossref","is-referenced-by-count":59,"title":["Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany"],"prefix":"10.1007","volume":"91","author":[{"name":"on behalf of the Heinz Nixdorf Recall Study Investigative Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewin","family":"Eisele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"D\u00fcrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"H\u00fcttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Assert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Bokhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund","family":"Erbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"J\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Moebus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,26]]},"reference":[{"issue":"5","key":"1293_CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121(5):749\u2013757","journal-title":"Br J Haematol"},{"issue":"13","key":"1293_CR2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354(13):1362\u20131369. doi: 10.1056\/NEJMoa054494","journal-title":"N Engl J Med"},{"key":"1293_CR3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/leu.2008.203","volume":"22","author":"J Blade","year":"2008","unstructured":"Blade J, Rosinol L, Cibeira MT, de Larrea CF (2008) Pathogenesis and progression of monoclonal gammopathy of undetermined significance. Leukemia 22:1651\u20131657. doi: 10.1038\/leu.2008.203","journal-title":"Leukemia"},{"issue":"8","key":"1293_CR4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346(8):564\u2013569. doi: 10.1056\/NEJMoa01133202","journal-title":"N Engl J Med"},{"issue":"22","key":"1293_CR5","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV (2009) Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113(22):5412\u20135417. doi: 10.1182\/blood-2008-12-194241","journal-title":"Blood"},{"issue":"22","key":"1293_CR6","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM (2009) A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 113(22):5418\u20135422. doi: 10.1182\/blood-2008-12-195008","journal-title":"Blood"},{"issue":"9727","key":"1293_CR7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","volume":"375","author":"A Dispenzieri","year":"2010","unstructured":"Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV (2010) Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet 375(9727):1721\u20131728. doi: 10.1016\/S0140-6736(10)60482-5","journal-title":"Lancet"},{"issue":"2","key":"1293_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mhj.2002.123579","volume":"144","author":"A Schmermund","year":"2002","unstructured":"Schmermund A, M\u00f6hlenkamp S, Stang A, Gr\u00f6nemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, J\u00f6ckel KH, Erbel R (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 144(2):212\u2013218","journal-title":"Am Heart J"},{"issue":"6","key":"1293_CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10654-005-5529-z","volume":"20","author":"A Stang","year":"2005","unstructured":"Stang A, Moebus S, Dragano N, Beck EM, M\u00f6hlenkamp S, Schmermund A, Siegrist J, Erbel R, J\u00f6ckel KH (2005) Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response. Eur J Epidemiol 20(6):489\u2013496","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"1293_CR10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA (2002) Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48(9):1437\u20131444","journal-title":"Clin Chem"},{"issue":"8","key":"1293_CR11","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/49.8.1252","volume":"49","author":"JR Tate","year":"2003","unstructured":"Tate JR, Gill D, Cobcroft R, Hickman PE (2003) Practical considerations for the measurement of free light chains in serum. Clin Chem 49(8):1252\u20131257","journal-title":"Clin Chem"},{"issue":"3","key":"1293_CR12","first-page":"1","volume":"47","author":"RN Anderson","year":"1998","unstructured":"Anderson RN, Rosenberg HM (1998) Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 47(3):1\u201316, 20","journal-title":"Natl Vital Stat Rep"},{"issue":"3","key":"1293_CR13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ, Larson DR, Plevak MF, Dispenzieri A, Katzmann JA (2005) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 106(3):812\u2013817. doi: 10.1182\/blood-2005-03-1038","journal-title":"Blood"},{"issue":"9","key":"1293_CR14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1373\/clinchem.2006.069104","volume":"52","author":"PG Hill","year":"2006","unstructured":"Hill PG, Forsyth JM, Rai B, Mayne S (2006) Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clin Chem 52(9):1743\u20131748. doi: 10.1373\/clinchem.2006.069104","journal-title":"Clin Chem"},{"issue":"11","key":"1293_CR15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrneph.2009.151","volume":"5","author":"CA Hutchison","year":"2009","unstructured":"Hutchison CA, Basnayake K, Cockwell P (2009) Serum free light chain assessment in monoclonal gammopathy and kidney disease. Nat Rev Nephrol 5(11):621\u2013628. doi: 10.1038\/nrneph.2009.151","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"1293_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1592\/phco.25.4.491.61034","volume":"25","author":"GR Bailie","year":"2005","unstructured":"Bailie GR, Uhlig K, Levey AS (2005) Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease. Pharmacotherapy 25(4):491\u2013502","journal-title":"Pharmacotherapy"},{"issue":"8","key":"1293_CR17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","volume":"55","author":"JA Katzmann","year":"2009","unstructured":"Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, Rajkumar SV, Dispenzieri A (2009) Screening panels for detection of monoclonal gammopathies. Clin Chem 55(8):1517\u20131522. doi: 10.1373\/clinchem.2009.126664","journal-title":"Clin Chem"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1293-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1293-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1293-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T16:10:29Z","timestamp":1592755829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1293-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,26]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1293-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,26]]}}}